GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (OTCPK:BAYZF) » Definitions » Marketable Securities

BAYZF (Bayer AG) Marketable Securities : $1,985 Mil (As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Bayer AG Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Bayer AG's Marketable Securities for the quarter that ended in Dec. 2024 was $1,985 Mil.

Bayer AG's annual Marketable Securities declined from Dec. 2022 ($5,278 Mil) to Dec. 2023 ($5,104 Mil) and declined from Dec. 2023 ($5,104 Mil) to Dec. 2024 ($1,985 Mil).


Bayer AG Marketable Securities Historical Data

The historical data trend for Bayer AG's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Marketable Securities Chart

Bayer AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,357.66 3,587.57 5,277.54 5,103.60 1,985.34

Bayer AG Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,103.60 4,561.96 6,604.95 1,908.99 1,985.34

Bayer AG Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Bayer AG  (OTCPK:BAYZF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Bayer AG Marketable Securities Related Terms

Thank you for viewing the detailed overview of Bayer AG's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG Business Description

Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm's crop science business sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.

Bayer AG Headlines

From GuruFocus

Bayer Crop Science ESG Investor Webinar Transcript

By GuruFocus Research 02-12-2024

Bayer AG at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-12-2024

Q1 2024 Bayer AG Earnings Call Transcript

By GuruFocus Research 05-15-2024

Q4 2023 Bayer AG Earnings Call Transcript

By GuruFocus Research 03-06-2024

Bayer AG Annual Shareholders Meeting Transcript

By GuruFocus Research 02-12-2024

Q2 2024 Bayer AG Earnings Call Transcript

By GuruFocus Research 08-07-2024

Bayer AG's Dividend Analysis

By GuruFocus Research 04-29-2024